主动脉干预中的急性肾损伤:MARI队列研究
这项多中心前瞻性队列研究纳入300例接受EVAR或开放主动脉修复的患者,按KDIGO标准评估术后急性肾损伤(AKI)。总体24%发生1期AKI,2.7%为2期,1%需肾脏替代治疗;分支EVAR和肾旁开放修复的AKI比例最高。年龄、基线肾功能和缺血性心脏病是主要预测因素,24%达到MAKE30终点。
要点
- 主动脉修复术后AKI常见,总体1期AKI达24%。
- 分支EVAR和肾旁开放修复的AKI比例最高(71%和63%)。
- 年龄、基线eGFR低和缺血性心脏病是主要预测因素。
核心结论
- 主动脉干预后AKI和短期肾功能下降常见,年龄、肾功能和心血管疾病是主要危险因素。
研究设计与样本
- 共纳入300例患者,平均年龄71岁(标准差4岁),女性占9%。
- 术后至少48小时或整个住院期间监测血肌酐和尿量,按KDIGO标准定义AKI。
主要发现
- 总体24%发生1期AKI(48小时KDIGO标准),2.7%为2期,1%出院前需肾脏替代治疗。
- 各干预AKI比例:肾下EVAR 18%,开窗EVAR 27%,分支EVAR 71%,肾下OAR 41%,肾旁OAR 63%。
- 肾下EVAR和OAR的AKI主要预测因素:年龄(OR 1.44 EVAR,1.58 OAR)、基线eGFR低(OR 0.88 EVAR,0.74 OAR)、缺血性心脏病(OR 4.42 EVAR,5.80 OAR)。
- 24%达到MAKE30复合终点;1年死亡(0.6%)或主要心脏事件(5.6%)的患者均曾发生AKI。
临床怎么用
- 对接受主动脉干预的患者,尤其高龄、基线肾功能差或合并缺血性心脏病者,应加强术后肾功能监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The incidence of acute kidney injury (AKI) after open (OAR) or endovascular (EVAR) aortic repair is unknown. This research assessed the proportion of patients who develop AKI after aortic intervention using validated criteria, and explored AKI risk factors. METHODS: This was a multicentre national prospective cohort study. Eleven centres recruited patients undergoing EVAR or OAR (September 2017-December 2018). Serum creatinine (SCr) and urine outputs were measured over a minimum of 48 h or throughout the index inpatient stay to define post-operative AKI using the Kidney Disease Improving Global Outcomes (KDIGO) criteria. Renal decline at 30 days was calculated using estimated glomerular filtration rate (eGFR) and the Major Adverse Kidney Events (MAKE) 30 day composite endpoint (consisting of: death, new dialysis, > 25% eGFR decline). RESULTS: 300 patients (mean age: 71 years, standard deviation [SD] 4 years; 9% females) were included, who underwent: infrarenal endovascular aneurysm repair (EVAR) 139 patients, fenestrated EVAR (fEVAR) 30, branched EVAR (bEVAR) seven, infrarenal open aneurysm repair (OAR) 98, juxtarenal OAR 26. Overall, 24% of patients developed stage 1 AKI (defined at 48 h as per KDIGO), 2.7% stage 2 AKI and 1% needed renal replacement therapy before discharge. AKI proportions per intervention were: infrarenal EVAR 18%; fEVAR 27%; bEVAR 71%; infrarenal OAR 41%; juxtarenal OAR 63%. Older age (odds ratio [OR] 1.44 for EVAR, 1.58 for OAR), lower baseline eGFR (OR 0.88 EVAR, 0.74 OAR), and ischaemic heart disease (OR 4.42 EVAR, 5.80 OAR) were the main predictors of AKI for infrarenal EVAR and OAR. Overall, 24% developed the MAKE30 endpoint. All patients who died (0.6%) or developed a major cardiac event (5.6%) at one year had developed AKI. CONCLUSION: AKI and short term renal decline after aortic intervention are common. Age, renal function, and cardiovascular disease are the main risk factors. Research should now focus on AKI prevention in this high risk group.
引用
- Saratzis A, Joshi S, Benson RA, et al. Editor's Choice - Acute Kidney Injury (AKI) in Aortic Intervention: Findings From the Midlands Aortic Renal Injury (MARI) Cohort Study. Eur J Vasc Endovasc Surg. 2019. PMID: 31870694. doi:10.1016/j.ejvs.2019.09.508
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。